Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Proinflammatory consequences of transgenic Fas ligand expression in the heart
David P. Nelson, … , Richard C. Duke, Jeffrey Robbins
David P. Nelson, … , Richard C. Duke, Jeffrey Robbins
Published May 1, 2000
Citation Information: J Clin Invest. 2000;105(9):1199-1208. https://doi.org/10.1172/JCI8212.
View: Text | PDF
Article

Proinflammatory consequences of transgenic Fas ligand expression in the heart

  • Text
  • PDF
Abstract

Expression of Fas ligand (FasL) renders certain tissues immune privileged, but its expression in other tissues can result in severe neutrophil infiltration and tissue destruction. The consequences of enforced FasL expression in striated muscle is particularly controversial. To create a stable reproducible pattern of cardiomyocyte-specific FasL expression, transgenic (Tg) mice were generated that express murine FasL specifically in the heart, where it is not normally expressed. Tg animals are healthy and indistinguishable from nontransgenic littermates. FasL expression in the heart does result in mild leukocyte infiltration, but despite coexpression of Fas and FasL in Tg hearts, neither myocardial tissue apoptosis nor necrosis accompanies the leukocyte infiltration. Instead of tissue destruction, FasL Tg hearts develop mild interstitial fibrosis, functional changes, and cardiac hypertrophy, with corresponding molecular changes in gene expression. Induced expression of the cytokines TNF-α, IL-1β, IL-6, and TGF-β accompanies these proinflammatory changes. The histologic, functional, and molecular proinflammatory consequences of cardiac FasL expression are transgene-dose dependent. Thus, coexpression of Fas and FasL in the heart results in leukocyte infiltration and hypertrophy, but without the severe tissue destruction observed in other examples of FasL-directed proinflammation. The data suggest that the FasL expression level and other tissue-specific microenvironmental factors can modulate the proinflammatory consequences of FasL.

Authors

David P. Nelson, Elizabeth Setser, D. Greg Hall, Steven M. Schwartz, Timothy Hewitt, Raisa Klevitsky, Hanna Osinska, Don Bellgrau, Richard C. Duke, Jeffrey Robbins

×

Total citations by year

Year: 2023 2021 2019 2015 2014 2013 2012 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Total
Citations: 1 2 1 2 4 2 3 4 1 2 2 3 5 9 8 9 7 65
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (65)

Title and authors Publication Year
Comparison of Cardioplegic Solutions in Coronary Bypass Surgery Over Autophagy and Apoptosis Mechanisms.
Sener EF, Hamurcu Z, Taheri S, Tahtasakal R, Delibasi N, Elcik D, Mehmetbeyoglu E, Tuncay A, Dal F, Bayram KK, Gunes I, Emirogullari ON
Arquivos brasileiros de cardiologia 2023
Biomarker profiles in obesity patients and their relation to cardiac dysfunction
SM Snelder, N Pouw, Y Aga, MC Cabezas, F Zijlstra, I Kardys, BM van Dalen
Biomarkers in Medicine 2021
Toxic effects and molecular mechanism of doxorubicin on different organs – an update
K Renu, LP Pureti, B Vellingiri, AV Gopalakrishnan
Toxin Reviews 2021
Genome Wide Meta-Analysis identifies common genetic signatures shared by heart function and Alzheimer’s disease
ME Sáez, A González-Pérez, B Hernández-Olasagarre, A Beà, S Moreno-Grau, I de Rojas, G Monté-Rubio, A Orellana, S Valero, JX Comella, D Sanchís, A Ruiz
Scientific Reports 2019
Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4+ T-cell mediated rejection
RJ Plenter, TJ Grazia, DP Nelson, MR Zamora, RG Gill, BA Pietra
Cellular Immunology 2015
Diabetic Cardiovascular Disease Induced by Oxidative Stress
Y Kayama, U Raaz, A Jagger, M Adam, I Schellinger, M Sakamoto, H Suzuki, K Toyama, J Spin, P Tsao
International journal of molecular sciences 2015
TWEAK-Fn14 Cytokine-Receptor Axis: A New Player of Myocardial Remodeling and Cardiac Failure
T Novoyatleva, A Sajjad, FB Engel
Frontiers in immunology 2014
Arachidonate 12/15-Lipoxygenase–Induced Inflammation and Oxidative Stress Are Involved in the Development of Diabetic Cardiomyopathy
H Suzuki, Y Kayama, M Sakamoto, H Iuchi, I Shimizu, T Yoshino, D Katoh, T Nagoshi, K Tojo, T Minamino, M Yoshimura, K Utsunomiya
Diabetes 2014
A Novel Role for SIRT-1 in L-Arginine Protection against STZ Induced Myocardial Fibrosis in Rats
SM Rizk, SA El-Maraghy, NN Nassar, DK Singla
PloS one 2014
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes
2014
Tumor Necrosis Factor Receptor–Associated Factor 2 Signaling Provokes Adverse Cardiac Remodeling in the Adult Mammalian Heart
VG Divakaran, S Evans, VK Topkara, A Diwan, J Burchfield, F Gao, J Dong, HP Tzeng, N Sivasubramanian, PM Barger, DL Mann
Circulation. Heart failure 2013
Cardiomyocyte apoptosis in the failing heart — A critical review from definition and classification of cell death
G Takemura, M Kanoh, S Minatoguchi, H Fujiwara
International Journal of Cardiology 2013
TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure
T Ueland, A Yndestad, CP Dahl, L Gullestad, P Aukrust
Current Heart Failure Reports 2012
Pre-existing fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of fasl expression after inoculation facilitates tumor formation
HY Chiu, GH Sun, SY Chen, HH Wang, MY Ho, CY Chu, WL Wu, RS Jhou, YL Tsai, RT Huang, KH Sun, SJ Tang
Molecular Carcinogenesis 2012
Protective effect of Tranilast on radiation-induced heart fibrosis in C57BL/6 mouse
S Moon
International Journal of Contents 2012
Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis
S Miyata, G Takemura, KI Kosai, T Takahashi, M Esaki, L Li, H Kanamori, R Maruyama, K Goto, A Tsujimoto, T Takeyama, T Kawaguchi, T Ohno, K Nishigaki, T Fujiwara, H Fujiwara, S Minatoguchi
The American Journal of Pathology 2010
Apoptosis in Cardiovascular Diseases: Mechanism and Clinical Implications
NH Kim, PM Kang
Korean Circulation Journal 2010
Effects of Fas-ligand overexpression on alveolar type II cell growth kinetics in perinatal murine lungs
ME de Paepe, SA Haley, Z Lacourse, Q Mao
Pediatric Research 2010
Comprehensive Toxicology
JM Sands, JW Verlander
Comprehensive Toxicology 2010
Is the Fas/Fas-L Pathway a Promising Target for Treating Inflammatory Heart Disease?
A Henriques-Pons, GM de Oliveira
Journal of Cardiovascular Pharmacology 2009
The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice
Q Mao, S Gundavarapu, C Patel, A Tsai, FI Luks, ME de Paepe
American journal of respiratory cell and molecular biology 2008
c-Flip overexpression reduces cardiac hypertrophy in response to pressure overload
C Giampietri, S Petrungaro, M Musumeci, P Coluccia, F Antonangeli, PD Cesaris, A Filippini, G Marano, E Ziparo
Journal of Hypertension 2008
Myocardial Fas Ligand Expression Increases Susceptibility to AZT-Induced Cardiomyopathy
E Purevjav, DP Nelson, JJ Varela, S Jimenez, DL Kearney, XV Sanchez, G DeFreitas, B Carabello, MD Taylor, M Vatta, WT Shearer, JA Towbin, NE Bowles
Cardiovascular Toxicology 2007
Handbook of Systemic Autoimmune Diseases
M Karmegam, RJ Quigg
Handbook of Systemic Autoimmune Diseases 2007
Mechanisms of malignant glioma immune resistance and sources of immunosuppression
GG Gomez, CA Kruse
Gene therapy & molecular biology 2006
The tumor necrosis factor superfamily in heart failure
T Ueland, P Aukrust, JK Damas, L Gullestad, A Yndestad
Future Cardiology 2006
Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1
J Niu, A Azfer, MF Deucher, PJ Goldschmidt-Clermont, PE Kolattukudy
Journal of Molecular and Cellular Cardiology 2006
Hydrogen peroxide predisposes neonatal rat ventricular myocytes to Fas-mediated apoptosis
G Yaniv, M Shilkrut, S Larisch, O Binah
Biochemical and Biophysical Research Communications 2005
Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis
X Liao, X Wang, Y Gu, Q Chen, LY Chen
Life Sciences 2005
Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
L Gullestad, P Aukrust
The American Journal of Cardiology 2005
Molecular Mechanisms of Cardiac Hypertrophy and Failure
W Dun, P Boyden
Molecular Mechanisms of Cardiac Hypertrophy and Failure 2005
Molecular Autoimmunity
M Zouali
2005
Nitric oxide and promotion of cardiac myocyte apoptosis
P Andréka, T Tran, KA Webster, NH Bishopric
Molecular and Cellular Biochemistry 2004
Fas ligand gene transfer to the embryonic heart induces programmed cell death and outflow tract defects
D Sallee, Y Qiu, J Liu, M Watanabe, SA Fisher
Developmental Biology 2004
Role of the Fas/Fas Ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in hepg2 cells
SH Oh, HQ Yin, BH Lee
Archives of Pharmacal Research 2004
Therapeutic Potential of Anticytokine Therapy in Congestive Heart Failure:
P Aukrust, A Yndestad, JK Dam??s, L Gullestad
American Journal of Cardiovascular Drugs 2004
Involvement of IL-17 in Fas ligand-induced inflammation
M Umemura, T Kawabe, K Shudo, H Kidoya, M Fukui, M Asano, Y Iwakura, G Matsuzaki, R Imamura, T Suda
International Immunology 2004
Bcl-2 Is a Key Factor for Cardiac Fibroblast Resistance to Programmed Cell Death
M Mayorga, N Bahi, M Ballester, JX Comella, D Sanchis
The Journal of biological chemistry 2004
The Regulation of Interleukin-6 Secretion by Prostanoids and Members of the Tumor Necrosis Factor Superfamily in Fresh Villous Fragments of Term Human Placenta
MA Turner, S Vause, SL Greenwood
Journal of the Society for Gynecologic Investigation 2004
Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS
EL Regardsoe, MM McMenamin, HM Charlton, MJ Wood
Gene Therapy 2004
Urocortin-II and Urocortin-III Are Cardioprotective against Ischemia Reperfusion Injury: An Essential Endogenous Cardioprotective Role for Corticotropin Releasing Factor Receptor Type 2 in the Murine Heart
BK Brar, AK Jonassen, EM Egorina, A Chen, A Negro, MH Perrin, OD Μjøs, DS Latchman, KF Lee, W Vale
Endocrinology 2004
Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases
PM Kang, S Izumo
Trends in Molecular Medicine 2003
Contribution of Fas to diabetes development
AY Savinov, A Tcherepanov, EA Green, RA Flavell, AV Chervonsky
Proceedings of the National Academy of Sciences 2003
Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion
QZ Feng, TD Li, LX Wei, X Qiao, J Yi, L Wang, TS Yang
Molecular pathology : MP 2003
Apoptosis and Plastic Surgery
BR Gastman, JW Futrell, EK Manders
Plastic and Reconstructive Surgery 2003
Regulation of cardiac myocyte cell death
A Clerk, SM Cole, TE Cullingford, JG Harrison, M Jormakka, DM Valks
Pharmacology & Therapeutics 2003
Apoptosis and Plastic Surgery:
BR Gastman, JW Futrell, EK Manders
Plastic and Reconstructive Surgery 2003
Endothelial Cell Overexpression of Fas Ligand Attenuates Ischemia-Reperfusion Injury in the Heart
J Yang, SP Jones, T Suhara, JJ Greer, PD Ware, NP Nguyen, H Perlman, DP Nelson, DJ Lefer, K Walsh
The Journal of biological chemistry 2003
Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo
P Lee, M Sata, DJ Lefer, SM Factor, K Walsh, RN Kitsis
American journal of physiology. Heart and circulatory physiology 2003
Fas receptor signaling inhibits GSK3beta in cardiomyocytes and is required for pressure overload-induced hypertrophy
Cornel Badorff, Hartmut Ruetten, Sven Mueller, Meike Stahmer, Doris Gehring, Frank Jung, Christian Ihling, Andreas M. Zeiher, Stefanie Dimmeler
Journal of Clinical Investigation 2002
The MEKK1-JNK pathway plays a protective role in pressure overload, but does not mediate cardiac hypertrophy
Junichi Sadoshima, Olivier Montagne, Qian Wang, Guiping Yang, Jill Warden, Jing Liu, Gen Takagi, Vijaya Karoor, Chull Hong, Gary L Johnson, Dorothy E Vatner, Stephen F Vatner
Journal of Clinical Investigation 2002
Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension
B Hocher, M Godes, J Olivier, J Weil, T Eschenhagen, T Slowinski, HH Neumayer, C Bauer, M Paul, YM Pinto
Journal of Hypertension 2002
New Insights Into the Role of Apoptosis in Cardiovascular Disease
PM Kang, P Yue, S Izumo
Circulation Journal 2002
Increased plasma levels of the soluble form of fas ligand in patients with acute myocardial infarction and unstable angina pectoris
M Shimizu, K Fukuo, S Nagata, T Suhara, M Okuro, K Fujii, Y Higashino, M Mogi, Y Hatanaka, T Ogihara
Journal of the American College of Cardiology 2002
Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3
Y Seko, N Kayagaki, K Seino, H Yagita, K Okumura, R Nagai
Journal of the American College of Cardiology 2002
Role of Fas/Fas Ligand Interaction in Ischemia-Induced Collateral Vessel Growth
M SATA, Y HIRATA, R NAGAI
Hypertension Research 2002
Tumor Necrosis Factor α Up-regulates Non-lymphoid Fas-ligand following Superantigen-induced Peripheral Lymphocyte Activation
MJ Pinkoski, NM Droin, DR Green
The Journal of biological chemistry 2002
Apoptosis and Heart Failure: Mechanisms and Therapeutic Implications
QM Chen, VC Tu
American Journal Cardiovascular Drugs 2002
Cardiac Myosin and the TH1/TH2 Paradigm in Autoimmune Myocarditis
MW Cunningham
The American Journal of Pathology 2001
Cardiac hypertrophy and failure: lessons learned from genetically engineered mice
Y Takeishi, RA Walsh
Acta Physiologica Scandinavica 2001
Apoptosis and its clinical impact
BR Gastman
Head & Neck 2001
Molecular mechanisms of apoptosis in the cardiac myocyte
N Bishopric
Current Opinion in Pharmacology 2001
Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1α
K Isoda, Y Kamezawa, N Tada, M Sato, F Ohsuzu
Journal of Cardiac Failure 2001
Akt Like a Woman: Gender Differences in Susceptibility to Cardiovascular Disease
PH Sugden, A Clerk
Circulation research 2001
Acute and Chronic Smooth Muscle Cell Apoptosis After Mechanical Vascular Injury Can Occur Independently of the Fas-Death Pathway
M Sata, S Sugiura, M Yoshizumi, Y Ouchi, Y Hirata, R Nagai
Arteriosclerosis, thrombosis, and vascular biology 2001

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts